Recombinant EGFR (Cetuximab Biosimilar) antibody

Catalog No. ABIN5668058

The Human Monoclonal anti-EGFR (Cetuximab Biosimilar) antibody (Clone C225) (ABIN5668058) specifically detects EGFR (Cetuximab Biosimilar) in FACS and BR. The antibody is reactive with Human samples.

Quick Overview for Recombinant EGFR (Cetuximab Biosimilar) antibody (ABIN5668058)

Target: EGFR (Cetuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This EGFR (Cetuximab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), Blocking Reagent (BR)

Clone: C225

Product Details anti-EGFR (Cetuximab Biosimilar) Antibody

Purpose: Anti-EGFR [C225 (Cetuximab)], Human IgG1, kappa

Specificity: Recognises human EGFR.

Characteristics:

Original Species of Ab: Human

Original Format of Ab: IgG1

Purification: Protein A affinity purified

Purity: > 98 % as determined by SDS-PAGE

Endotoxin Level: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogen: The epidermal growth factor receptor is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands.

Isotype: IgG1 kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Target Details for EGFR (Cetuximab Biosimilar)

Target: EGFR (Cetuximab Biosimilar)

Target Type: Biosimilar

Background: EGFR, ErbB-1, HER1, epidermal growth factor receptor

UniProt: P00533